Research ArticleBasic Science Investigations
Comparison of the Hypoxia PET Tracer 18F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models
Satish K. Chitneni, Gerald T. Bida, Michael R. Zalutsky and Mark W. Dewhirst
Journal of Nuclear Medicine July 2014, 55 (7) 1192-1197; DOI: https://doi.org/10.2967/jnumed.114.137448
Satish K. Chitneni
1Department of Radiology, Duke University Medical Center, Durham, North Carolina; and
Gerald T. Bida
1Department of Radiology, Duke University Medical Center, Durham, North Carolina; and
Michael R. Zalutsky
1Department of Radiology, Duke University Medical Center, Durham, North Carolina; and
2Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina
Mark W. Dewhirst
2Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 7
July 1, 2014
Comparison of the Hypoxia PET Tracer 18F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models
Satish K. Chitneni, Gerald T. Bida, Michael R. Zalutsky, Mark W. Dewhirst
Journal of Nuclear Medicine Jul 2014, 55 (7) 1192-1197; DOI: 10.2967/jnumed.114.137448